Digital Weight Loss Intervention for Obesity and Type 2 Diabetes Risk
(mLIFE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a digital app can aid in weight loss and reduce the risk of type 2 diabetes. The app, called mLIFE, uses engaging, game-like features to promote healthy habits, such as tracking food intake and obtaining social support. Researchers aim to determine if the gaming version of the app results in greater weight loss and improved social support compared to the non-gaming version. The trial seeks adults who are overweight, own a smartphone, and have three or more risk factors for type 2 diabetes. As an unphased trial, it offers participants the chance to contribute to innovative research that could lead to new, engaging methods for managing weight and preventing diabetes.
Will I have to stop taking my current medications?
The trial requires that you do not use medications that may impact blood glucose. If you are taking such medications, you may need to stop them to participate.
What prior data suggests that this digital intervention is safe for weight loss?
Research has shown that the mLIFE app, tested for weight loss, may help people manage their weight and lower the risk of type 2 diabetes. The app allows users to track habits and receive support from others. Studies have found that mobile apps like mLIFE can improve self-care and diabetes control, suggesting they are generally safe.
The mLIFE app also uses social gaming to encourage weight loss by awarding points for social support. Previous research found this game-like approach effectively increases engagement without major safety concerns. Overall, these features are well-tolerated, with no significant reports of negative effects from using the app.
In summary, the mLIFE app's features appear safe based on existing research about similar mobile health tools. However, as with any new treatment, individuals should consider their own health conditions and consult healthcare providers before participating.12345Why are researchers excited about this trial?
Researchers are excited about the mLIFE app treatments for obesity and Type 2 diabetes risk because they offer a unique approach by integrating digital tools for self-regulation and social support. Unlike traditional methods like diet plans and medications, the mLIFE app introduces a gamified experience, fostering healthy competition among users to encourage sustained engagement and motivation. This social gaming element aims to make weight loss efforts more interactive and enjoyable, potentially leading to better adherence and outcomes. Moreover, the app's self-regulation features empower users to track their progress and make informed decisions, distinguishing it from more passive treatment options.
What evidence suggests that this digital weight loss intervention could be effective for obesity and Type 2 diabetes risk?
Research has shown that the mLIFE app, which aids in self-control and support from others, can effectively assist with weight loss. In this trial, participants will be assigned to different groups using the mLIFE app. One group will use a gamified version of the app, which includes points to encourage support from friends, resulting in more weight loss than similar programs without this feature. This version allows users to send encouraging messages and "likes" to each other upon reaching goals, fostering a supportive community. Early results suggest that adding game-like features enhances effectiveness, leading to greater weight loss. Evidence indicates that these social features can help individuals with obesity or at risk for Type 2 diabetes lose weight over 12 months.36789
Who Is on the Research Team?
Brie Turner-McGrievy, PhD, MS, RD
Principal Investigator
University of South Carolina
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with obesity or overweight, having a BMI of 25-49.9 kg/m2 and at least three risk factors for Type 2 diabetes but not diagnosed with it. Participants must own a smartphone, be willing to change their diet and exercise habits, and not be on medications affecting blood glucose or involved in other weight loss programs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Orientation and Baseline Assessment
Participants attend a study orientation, complete all baseline measures, and are randomized into groups
Intervention
Participants engage in a 1-year behavioral intervention using the mLIFE app, with or without gamification, including twice-weekly podcasts and daily tracking
Assessment
Participants complete assessments at 6 and 12 months to evaluate changes in weight, diet, and physical activity
Follow-up
Participants are monitored for sustained weight loss and behavioral changes after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- mLIFE app (self-regulation features)
- mLIFE app (social support features)
- Podcasts and tips of the day (within app)
- standard mLIFE app (social support features)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Carolina
Lead Sponsor